Company page
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. is a public biotechnology company based in the United States, trading under the ticker STRO. The company has a market capitalization of approximately $490.98 million. Sutro focuses on developing innovative therapeutics using its proprietary cell-free protein synthesis platform.
- Ticker
- STRO:NASDAQ
- Asset type
- Stock
- Market cap
- $491.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD